Key facts
- Cecelia Health’s last known valuation is $26.3M (Nov 2019).
- It has raised $54.3M across 4 recorded rounds; the latest was Seed Round ($1.2M) in Nov 2019.
- Notable investors include SJF Ventures, Esther Dyson, Steyn Group, Croft & Bender, Almero Holdings UK — 16 tracked in total.
- Cecelia Health has filed 4 Form Ds with the SEC since 2019, most recently May 2020 ($2.6M sold to 31 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Cecelia Health
Funding rounds
4 roundsAbout Cecelia Health
Operator of the virtual specialty care platform intended to positively transform the lives of people living with diabetes and related chronic diseases. The company's platform offers virtual care management and clinical support, an appropriate range of care from prevention to prescribing treatment, addressing a range of conditions, enabling specialized expert clinicians to work directly with patients through personalized coaching to improve self-management, drive behavior change, and improve health outcomes.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2009
- Employees
- 237
- Website
- ceceliahealth.com/
- Ownership
- Privately Held (backing)
Cecelia Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cecelia Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cecelia Health in its N-PORT filings yet. We sweep new filings monthly.